Racially classified social group tobacco-related health disparities: what is the role of genetics?
Certain racially classified social groups suffer disproportionately from tobacco-caused morbidity and mortality. Recent advances in genetics are leading researchers to examine variables that may account for this. However, it is critical that investigators proceed with caution and utilize transdisciplinary approaches. A number of fundamental questions might be used to stimulate consensus building in this area of science. What is race and how should its complexity be operationalized? Is it possible/likely that pharmacogenetics will allow us to match smokers with cessation strategies based on a gene-psychological profile? What are the most important conceptual and methodological issues for a research agenda in this area?
Fernander
Anita F
AF
University of Kentucky, College of Medicine, Department of Behavioral Science, 103 College of Medicine Office Building, Lexington, KY, USA. afern2@uky.edu
D005006:Ethnicity / Q000235:genetics*; D006304:Health Status; D006801:Humans; D010597:Pharmacogenetics; D014029:Tobacco Use Disorder / Q000188:drug therapy / Q000208:ethnology / Q000235:genetics*